HIGHLIGHTS
- who: Chen Lyu and collaborators from the Tumor Immunology Laboratory, LIFE Center, LMU Klinikum, University Munich, Planegg, Germany have published the article: A Pan-Cancer Landscape of ABCG2 across Human Cancers: Friend or Foe?, in the Journal: (JOURNAL) of 24/Oct/2022
- what: The authors explore multiple databases such as TCGA to investigate the potential therapeutic roles of ABCG2 across 33 different tumors. The authors investigated the association of ABCG2 with stem_cell-like features using the RNAss and DNAss scores . One of the main reasons for the association between gene alteration and clinical features may . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.